CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,154,003
- in 2 filings, $5.2M under 10b5-1 plans
Net −$5,154,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −2,996 | $80.47 | $241K | 97,704 |
| 2026-11-10 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −200 | $81.05 | $16K | 97,504 |
| 2026-11-10 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −900 | $83.33 | $75K | 96,604 |
| 2026-11-10 | Bickerstaff George Director | Option exercise | +15,000 | $14.74 | $221K | 149,061 |
| 2026-11-10 | Bickerstaff George Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2026-11-06 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −1,505 | $78.56 | $118K | 100,700 |
| 2026-11-05 | Kennedy Keith CFO & COO | Option exercise 10b5-1 | +52,422 | $29.43 | $1.5M | 261,108 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −28,256 | $76.55 | $2.2M | 232,852 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −12,380 | $77.42 | $958K | 220,472 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −6,897 | $78.59 | $542K | 213,575 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −7,415 | $79.49 | $589K | 206,160 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −3,403 | $80.38 | $274K | 202,757 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −2,710 | $81.40 | $221K | 200,047 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −300 | $82.08 | $25K | 199,747 |
| 2026-11-05 | Kennedy Keith CFO & COO | Sale 10b5-1 | −600 | $83.60 | $50K | 199,147 |
| 2026-11-05 | Kennedy Keith CFO & COO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −52,422 | 48,229 | ||
| 2026-11-03 | Cohen Fred E Director | Gift | −25,000 | 140,060 | ||
| 2026-11-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,873 | $85.88 | $247K | 102,205 |
| 2026-10-02 | Goldberg Michael Director | Grant or award | +588 | 62,326 | ||
| 2026-10-01 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −2,619 | $66.23 | $173K | 158,980 |
Page 1 of 17 · 324 trades